Next Science Share Price and Company Fundamentals



Price
$1.38
Change
0.030 (2.222%)
52 week
1.1 - 2.06

Last traded: Last Friday at 6:10 AM

Next Science Limited, a medical technology company, researches, develops, and commercializes technologies to eradicate issues in human health caused by biofilms. The company develops its products using its Xbio Technology platform. It offers SURGX, an antimicrobial gel designed to reduce surgical site and post-surgical infections; and BACTISURE, a surgical lavage that is used to wash out the surgery site and Intramedullary canal. The company also provides BlastX, an antimicrobial wound gel that destroys bacteria within the gel and defends from recolonization while maintaining a moist wound environment; and XPERIENCE, an no rinse antimicrobial solution that helps prevent surgical site and post-operative infections. It has strategic partnerships with Montana State University Center for Biofilm Engineering, Mayo Clinic, Texas Tech University Clinical Research Institute, Southwest Regional Wound Care Center, University of Florida Department of Otolaryngology, and Jacksonville Center for Clinical Research. Next Science Limited has operations in the United States and Australia. The company was founded in 2012 and is headquartered in Chatswood, Australia.

Key Metrics

PE ratio

-

PB ratio

17.04

Dividend yield

Beta

0.49

Market cap

$273.2M

Enterprise value

$260.39M

Company profile

Primary activitiesCommercialising and developing its Xbio technology, which is a non-toxic technology with proven efficacy in eradicating both biofilm based and free-floating bacteria, in a range of products for the treatment of biofilm based infections.
Industry / SectorDrug Manufacturers—Specialty & Generic / Healthcare
Websitehttp://www.nextscience.com
Mailing addressThe Zenith Building, Tower A Suite 1902 Level 19 821 Pacific Highway Chatswood NSW 2067 Australia
Phone / Fax61 2 8607 5124 /
Share registryLINK MARKET SERVICES LIMITED

Dividends

Next Science does not pay dividends.

Company Executives

As of Sep 2021, following are the company executives and directors listed on Next Science.

NameTitleAgeTotal Pay
Ms. Judith Mitchell M.B.A.MD, CEO & Exec. Director276.28k
Dr. Matthew MynttiFounder & CTO350k
Ms. Jacqueline Butler CA (ICAEW)Chief Financial Officer185.88k
Mr. Jon SwansonChief Operating Officer250k
Mr. Dustin HainesChief Commercial Officer331.17k
Ms. Gillian Maria Nairn AGIA, B.A., BA, L.L.B., L.L.M., LLB, LLM, MAICDCompany Sec.

Profitability and management effectiveness

Profit margin

-149.42%

Operating margin

-156.87%

Return on assets

-34.83%

Return on equity

-65.38%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Next Science is 273.2M and its enterprise value is 260.39M. The enterprise value to revenue ratio of NXS is 41.32.

The NXS's stocks Beta value is 0.49 making it 51% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Next Science (NXS)

Next Science (ASX:NXS) Frequently Asked Questions

1. What is Next Science's Stock Symbol?

Next Science trades on ASX under the ticker symbol "NXS".

2. What is Next Science's stock price today?

One share of NXS stock can currently be purchased for approximately $1.38.

3. How can I contact Next Science?

Next Science's mailing address is The Zenith Building, Tower A Suite 1902 Level 19 821 Pacific Highway Chatswood NSW 2067 Australia. The company can be reached via phone at 61 2 8607 5124.

4. What is Next Science's official website?

The official website of Next Science is http://www.nextscience.com.

5. Which share registry manages Next Science's stock?

Next Science's stock is managed by LINK MARKET SERVICES LIMITED.